BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 20575654)

  • 1. Transdermal estradiol and oral or vaginal natural progesterone: bleeding patterns.
    Di Carlo C; Tommaselli GA; Gargano V; Savoia F; Bifulco G; Nappi C
    Climacteric; 2010 Oct; 13(5):442-6. PubMed ID: 20575654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of continuous and sequential transdermal progestogen with sequential oral progestogen in postmenopausal women using continuous transdermal estrogen: vasomotor symptoms, bleeding patterns, and serum lipids.
    Rozenberg S; Ylikorkala O; Arrenbrecht S
    Int J Fertil Womens Med; 1997; 42 Suppl 2():376-87. PubMed ID: 9397385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bleeding patterns during continuous estradiol with different sequential progestogens therapy.
    Di Carlo C; Sammartino A; Di Spiezio Sardo A; Tommaselli GA; Guida M; Mandato VD; D'Elia A; Nappi C
    Menopause; 2005; 12(5):520-5. PubMed ID: 16145305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endometrial effects, bleeding control, and compliance with a new postmenopausal hormone therapy regimen based on transdermal estradiol gel and every-other-day vaginal progesterone in capsules: a 3-year pilot study.
    Cicinelli E; de Ziegler D; Alfonso R; Nicoletti R; Bellavia M; Colafiglio G
    Fertil Steril; 2005 Jun; 83(6):1859-63. PubMed ID: 15950667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of transdermal and oral sequential gestagen in combination with transdermal estradiol: effects on bleeding patterns and endometrial histology.
    Ross AH; Boyd ME; Colgan TJ; Ferenczy A; Fugere P; Lorrain J
    Obstet Gynecol; 1993 Nov; 82(5):773-9. PubMed ID: 8414325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transdermal sequential and continuous hormone replacement regimens with estradiol and norethisterone acetate in postmenopausal women: effects on the endometrium.
    Johannisson E; Holinka CF; Arrenbrecht S
    Int J Fertil Womens Med; 1997; 42 Suppl 2():388-98. PubMed ID: 9397386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bleeding patterns in postmenopausal women taking continuous combined or sequential regimens of conjugated estrogens with medroxyprogesterone acetate. Menopause Study Group.
    Archer DF; Pickar JH; Bottiglioni F
    Obstet Gynecol; 1994 May; 83(5 Pt 1):686-92. PubMed ID: 8164926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bleeding profiles and effects on the endometrium for women using a novel combination of transdermal oestradiol and natural progesterone cream as part of a continuous combined hormone replacement regime.
    Vashisht A; Wadsworth F; Carey A; Carey B; Studd J
    BJOG; 2005 Oct; 112(10):1402-6. PubMed ID: 16167944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endometrial response to a cyclic regimen of percutaneous 17beta-estradiol and low-dose vaginal micronized progesterone in women with mild-to-moderate hypertension.
    Vilodre LC; Osório Wender MC; Sisson de Castro JA; dos Reis FM; Ruschel S; Magalhães JA; Spritzer PM
    Gynecol Endocrinol; 2003 Aug; 17(4):323-8. PubMed ID: 14503977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endometrial morphology during hormone replacement therapy with estradiol gel combined to levonorgestrel-releasing intrauterine device or natural progesterone.
    Suvanto-Luukkonen E; Malinen H; Sundström H; Penttinen J; Kauppila A
    Acta Obstet Gynecol Scand; 1998 Aug; 77(7):758-63. PubMed ID: 9740525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One-year endometrial safety evaluation of a continuous combined transdermal matrix patch delivering low-dose estradiol-norethisterone acetate in postmenopausal women.
    Samsioe G; Dvorak V; Genazzani AR; Hamann B; Heikkinen J; Mueck AO; Suzin J; Kawakami FT; Ferreira A; Sun D; Arguinzoniz M
    Maturitas; 2007 Jun; 57(2):171-81. PubMed ID: 17317046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endometrial effect of progesterone delivered by vaginal rings in estrogen-treated postmenopausal women.
    Noé G; Sitruk-Ware R; Zegers-Hochschild F; Variano B; Montero JC; Arriagada P; Li A; Stanczyk FZ; Felix JC; Mishell DR; Croxatto HB
    Climacteric; 2010 Oct; 13(5):433-41. PubMed ID: 20642326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaginal ring delivering estradiol and progesterone: a possible alternative to relieve climacteric symptoms.
    Ben-Chetrit A; Hochner-Celnikier D; Lindenberg T; Zacut D; Shimonovitz S; Gelber H; Spitz IM
    Isr Med Assoc J; 2005 May; 7(5):302-6. PubMed ID: 15909462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of a constant-estrogen, pulsed-progestin regimen in hormone replacement therapy.
    Sulak PJ; Caubel P; Lane R
    Int J Fertil Womens Med; 1999; 44(6):286-96. PubMed ID: 10617250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endometrial safety and bleeding patterns during a 2-year study of 1 or 2 mg 17 beta-estradiol combined with sequential 5-20 mg dydrogesterone.
    Ferenczy A; Gelfand MM; van de Weijer PH; Rioux JE
    Climacteric; 2002 Mar; 5(1):26-35. PubMed ID: 11974556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endometrial response to concurrent treatment with vaginal progesterone and transdermal estradiol.
    Fernández-Murga L; Hermenegildo C; Tarín JJ; García-Pérez MÁ; Cano A
    Climacteric; 2012 Oct; 15(5):455-9. PubMed ID: 22321028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Amenorrhea during menopausal hormone replacement therapy with a percutaneous estradiol and oral micronized progesterone combination].
    Faguer B; Gillet JY; André G; Philippe E
    Contracept Fertil Sex; 1993 Nov; 21(11):849-52. PubMed ID: 8281238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
    Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
    Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of ultralow-dose transdermal estradiol on postmenopausal symptoms in women aged 60 to 80 years.
    Diem S; Grady D; Quan J; Vittinghoff E; Wallace R; Hanes V; Ensrud K
    Menopause; 2006; 13(1):130-8. PubMed ID: 16607109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of transdermal and oral estrogen replacement on lipids and glucose metabolism in postmenopausal women with type 2 diabetes mellitus.
    Araújo DA; Farias ML; Andrade AT
    Climacteric; 2002 Sep; 5(3):286-92. PubMed ID: 12419087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.